Mrv1718010311712592D 19 19 0 0 0 0 999 V2000 -0.0771 -2.4908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3465 1.1694 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.2247 0.8398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9390 1.2527 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.9390 2.0778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6533 2.4908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6667 1.6561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2244 2.4900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2248 0.0147 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.4894 -0.3982 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.2040 0.0140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6665 -0.7007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6667 0.7285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4894 -1.2218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1776 -1.7065 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.9017 -2.4908 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.1564 -1.7065 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7010 -0.2600 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.4897 0.1514 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 15 1 0 0 0 0 1 16 2 0 0 0 0 3 2 2 0 0 0 0 3 9 1 0 0 0 0 3 4 1 0 0 0 0 5 4 1 0 0 0 0 5 6 1 0 0 0 0 5 7 1 0 0 0 0 5 8 1 0 0 0 0 10 9 1 0 0 0 0 18 9 1 0 0 0 0 11 10 1 0 0 0 0 14 10 1 0 0 0 0 10 19 1 1 0 0 0 11 12 1 0 0 0 0 11 13 1 0 0 0 0 14 15 1 0 0 0 0 14 17 2 0 0 0 0 17 16 1 0 0 0 0 M END > DB08337 > drugbank > [H]N(C(=O)OC(C)(C)C)[C@@]([H])(C(C)C)C1=NN=CO1 > InChI=1S/C11H19N3O3/c1-7(2)8(9-14-12-6-16-9)13-10(15)17-11(3,4)5/h6-8H,1-5H3,(H,13,15)/t8-/m0/s1 > PARUDDGQWSBIIO-QMMMGPOBSA-N > C11H19N3O3 > 241.2869 > 241.142641489 > 5 > 36 > 25.161368495293488 > 1 > 1 > 0 > 1 > N-[(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl](tert-butoxy)carboximidic acid > 1.20 > 1.8885147389999988 > -2.69 > 0 > 1 > 0 > 3.5707183998403735 > 0.8042898134019562 > 80.74000000000001 > 63.9371 > 5 > 1 > 4.90e-01 g/l > N-[(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl](tert-butoxy)carboximidic acid > 0 > DB08337 > experimental > 2-Methyl-2-propanyl [(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate $$$$